Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05902169
What this trial is testing

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM
CarThera 560
Testing effectiveness (Phase 2)Study completedNCT03310372
What this trial is testing

Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Central Hospital, Nancy, France 46
Not applicableActive Not RecruitingNCT02375841
What this trial is testing

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

Who this might be right for
Brain CancerGlioblastoma
Memorial Sloan Kettering Cancer Center 309
Testing effectiveness (Phase 2)Ended earlyNCT01122901
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 47
Not applicableLooking for participantsNCT04047264
What this trial is testing

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Who this might be right for
GliomaGlioblastomaMetastatic Malignant Neoplasm in the Brain
Mayo Clinic 100
Early research (Phase 1)Ended earlyNCT00516282
What this trial is testing

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 14
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Not applicableUnknownNCT01317888
What this trial is testing

Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAstrocytoma Anaplastic Foci
Drexel University 11
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT02149459
What this trial is testing

Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy

Who this might be right for
Brain Neoplasms
Sheba Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Not applicableAvailableNCT07748299
What this trial is testing

NuvOx Expanded Access

Who this might be right for
GlioblastomaRespiratory Distress SyndromIschemic Stroke+1 more
NuvOx LLC
Testing effectiveness (Phase 2)Ended earlyNCT00479765
What this trial is testing

/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Who this might be right for
Glioblastoma MultiformeBrain Neoplasms
Boston Scientific Corporation 4
Not applicableLooking for participantsNCT07831772
What this trial is testing

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor
University of Minnesota 4
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Large-scale testing (Phase 3)Study completedNCT00154375
What this trial is testing

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT00093964
What this trial is testing

Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

Who this might be right for
Glioblastoma Multiforme
EMD Serono 81
Testing effectiveness (Phase 2)Looking for participantsNCT07391215
What this trial is testing

5G-PEARL: Paxalisib in Malignant Brain Tumours

Who this might be right for
Malignant Primary GliomasGlioblastoma Multiforme (GBM)
Institute of Cancer Research, United Kingdom 64
Very early researchLooking for participantsNCT07493447
What this trial is testing

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Who this might be right for
MeningiomaGlioblastomaAcoustic Neuroma+2 more
Eben Rosenthal 30
Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Next Page